|
Title
|
|
|
|
Phase
|
|
|
|
Protocol
IDs
|
|
|
|
Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma
|
|
|
|
Phase III
|
|
|
|
MRC-BR12
EU-20114, ISRCTN83176944, NCT00052455
|
|
|
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer
|
|
|
|
Phase III
|
|
|
|
RTOG-0320
NCT00096265
|
|
|
A Trial Comparing Radiosurgery With Surgery for Solitary Brain Metastases
|
|
|
|
Phase III
|
|
|
|
021108
NCT00124761
|
|
|
Radiation Therapy or Temozolomide in Treating Patients With Gliomas
|
|
|
|
Phase III
|
|
|
|
EORTC-22033
EORTC-26033, EudraCT-2004-002714-11, CAN-NCIC-CE5, NCT00182819, TROG 06.01, CE5
|
|
|
Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC
|
|
|
|
Phase III
|
|
|
|
TASMC-05-FB-05235-CTIL
NCT00268684
|
|
|
Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
|
|
|
|
Phase III
|
|
|
|
RTOG-0525
EORTC-26052, EORTC-22053, NCT00304031
|
|
|
A Trial of Postoperative Whole Brain Radiation Therapy vs. Salvage Stereotactic Radiosurgery Therapy for Metastasis
|
|
|
|
Phase III
|
|
|
|
JCOG0504
C000000307, NCT00280475
|
|
|
Comparing 2 Forms of Head Immobilization for Stereotactic Radiotherapy
|
|
|
|
Phase III
|
|
|
|
04U.534
NCT00328510
|
|
|
Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
|
|
|
|
Phase III
|
|
|
|
NCCTG-N0574
N0574, ACOSOG-N0574, NCT00377156
|
|
|
Effect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM)
|
|
|
|
Phase III
|
|
|
|
EF-11
NCT00379470
|
|